Epigenetic biomarkers in prostate cancer: Current and future uses

K Chiam, C Ricciardelli, T Bianco-Miotto - Cancer letters, 2014 - Elsevier
Epigenome alterations are characteristic of nearly all human malignancies and include
changes in DNA methylation, histone modifications and microRNAs (miRNAs). However …

Epigenetic biomarkers in prostate cancer: Current and future uses.

K Chiam, C Ricciardelli… - Cancer Letters, 2014 - researchnow.flinders.edu.au
Epigenome alterations are characteristic of nearly all human malignancies and include
changes in DNA methylation, histone modifications and microRNAs (miRNAs). However …

Epigenetic biomarkers in prostate cancer: Current and future uses

K Chiam, C Ricciardelli, T Bianco-Miotto - Cancer Letters, 2014 - infona.pl
Epigenome alterations are characteristic of nearly all human malignancies and include
changes in DNA methylation, histone modifications and microRNAs (miRNAs). However …

Epigenetic biomarkers in prostate cancer: Current and future uses

K Chiam, C Ricciardelli, T Bianco-Miotto - Cancer letters, 2014 - pubmed.ncbi.nlm.nih.gov
Epigenome alterations are characteristic of nearly all human malignancies and include
changes in DNA methylation, histone modifications and microRNAs (miRNAs). However …

Epigenetic biomarkers in prostate cancer: current and future uses

K Chiam, C Ricciardelli, T Bianco-Miotto - 2014 - hekyll.services.adelaide.edu.au
Epigenome alterations are characteristic of nearly all human malignancies and include
changes in DNA methylation, histone modifications and microRNAs (miRNAs). However …

[引用][C] Epigenetic biomarkers in prostate cancer: Current and future uses

K Chiam, C Ricciardelli, T Bianco-Miotto - Cancer Letters, 2014 - cir.nii.ac.jp
Epigenetic biomarkers in prostate cancer: Current and future uses | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Epigenetic biomarkers in prostate cancer: Current and future uses.

K Chiam, C Ricciardelli, T Bianco-Miotto - Cancer Letters, 2012 - europepmc.org
Epigenome alterations are characteristic of nearly all human malignancies and include
changes in DNA methylation, histone modifications and microRNAs (miRNAs). However …

Epigenetic biomarkers in prostate cancer: current and future uses

K Chiam, C Ricciardelli, T Bianco-Miotto - 2014 - digital.library.adelaide.edu.au
Epigenome alterations are characteristic of nearly all human malignancies and include
changes in DNA methylation, histone modifications and microRNAs (miRNAs). However …

[引用][C] Epigenetic biomarkers in prostate cancer: Current and future uses

K Chiam, C Ricciardelli, T Bianco-Miotto - Cancer Letters, 2014 - Elsevier Limited